MedPath

Postoperative Desogestrel for Endometriosis Related Pain

Not Applicable
Completed
Conditions
Endometriosis
Interventions
Drug: Placebo
Registration Number
NCT01559480
Lead Sponsor
Mahidol University
Brief Summary

Endometriosis is one of the most common disease in reproductive aged women.Surgical intervention has a significant symptoms relief. However, symptom recurrence is often after surgery. This study aims to determine the efficacy of Desogestrel compared with placebo in pain symptom of symptomatic endometriosis patient undergo conservative surgery . The primary outcome measurement is pain score at 6 months after surgery.

Detailed Description

After conservative surgery, the patients are randomized to Desogestrel and placebo groups. VAS pain score are compared after complete 6 months

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • diagnoses endometriosis
  • Plan conservative surgery
  • initial pain score at least 5
  • voluntary to be the participant of this study with inform consent
  • No desired child bearing in 6 months
Exclusion Criteria
  • residual lesion after surgery which required further treatment
  • cannot participate complete 6 months after surgery
  • contraindication for Desogestrel, Paracetamol or Ponstan
  • Pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
DesogestrelDesogestrel-
Primary Outcome Measures
NameTimeMethod
Pain score6 months

Pain score will be assessed by visual analog scale (0-10)

Secondary Outcome Measures
NameTimeMethod
Side effect compared between both group6 month
Patients satisfaction compare between both groups6 months

Trial Locations

Locations (2)

Faculty of medicine Siriraj hospital, Mahidol university

🇹🇭

Bangkok noi, Bangkok, Thailand

Siriraj hospital Mahidol university

🇹🇭

Bangkok noi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath